27706 Federal Register / Vol. 74, No. 111 / Thursday, June 11, 2009 / Rules and Regulations 

For the reasons discussed above, I 

certify that this AD: 

(1) Is not a ‘‘significant regulatory 

action’’ under Executive Order 12866, 

(2) Is not a ‘‘significant rule’’ under 

DOT Regulatory Policies and Procedures 

(44 FR 11034, February 26, 1979), and 

(3) Will not have a significant 

economic impact, positive or negative, 

on a substantial number of small entities 

under the criteria of the Regulatory 

Flexibility Act. 

You can find our regulatory 

evaluation and the estimated costs of 

compliance in the AD Docket. 

List of Subjects in 14 CFR Part 39 

Air transportation, Aircraft, Aviation 

safety, Incorporation by reference, 

Safety. 

Adoption of the Amendment 

■ Accordingly, under the authority 

delegated to me by the Administrator, 

the FAA amends 14 CFR part 39 as 

follows: 

PART 39—AIRWORTHINESS 

DIRECTIVES 

■ 1. The authority citation for part 39 

continues to read as follows: 

Authority: 49 U.S.C. 106(g), 40113, 44701. 

§ 39.13 [Amended] 

■ 2. The FAA amends § 39.13 by adding 

the following new AD: 

2009–12–03 Boeing: Amendment 39–15926. 

Docket No. FAA–2007–29067; 

Directorate Identifier 2007–NM–148–AD. 

Effective Date 

(a) This airworthiness directive (AD) is 

effective July 16, 2009. 

Affected ADs 

(b) None. 

Applicability 

(c) This AD applies to Boeing Model 757– 

200, –200CB, and –300 series airplanes; 

certificated in any category; as identified in 

Boeing Service Bulletin 757–21–0109, 

Revision 1, dated October 30, 2008. 

Unsafe Condition 

(d) This AD results from a report indicating 

that, during landing of a Model 757 airplane, 

an overheat warning and smoke occurred in 

the main cabin, and the right recirculation 

fan stopped operating. We are issuing this 

AD to prevent damage of the wiring bundle 

of the right recirculation fan. Such damage 

could result in a short circuit and possible 

fire in the mix bay or smoke in the main 

cabin. 

Compliance 

(e) You are responsible for having the 

actions required by this AD performed within 

the compliance times specified, unless the 

actions have already been done. 

Inspection and Corrective Actions 

(f) Within 24 months after the effective 

date of this AD, do the actions required by 

paragraphs (f)(1) and (f)(2) of this AD, in 

accordance with the Accomplishment 

Instructions of Boeing Service Bulletin 757– 

21–0109, Revision 1, dated October 30, 2008. 

(1) Do a detailed inspection for damage of 

the wire bundle of the right recirculation fan, 

and repair any damage before further flight. 

(2) Re-route the wire bundle and re-orient 

the electrical connector of the right 

recirculation fan. 

Credit for Actions Done According to 

Previous Issue of Service Bulletin 

(g) Actions done before the effective date 

of this AD in accordance with Boeing Service 

Bulletin 757–21–0109, dated December 15, 

2006, are acceptable for compliance with the 

requirements of paragraphs (f)(1) and (f)(2) of 

this AD. 

Alternative Methods of Compliance 

(AMOCs) 

(h)(1) The Manager, Seattle Aircraft 

Certification Office, FAA, has the authority to 

approve AMOCs for this AD, if requested 

using the procedures found in 14 CFR 39.19. 

Send information to Attn: Philip Sheridan, 

Systems and Equipment Branch, ANM–130S, 

FAA, Seattle Aircraft Certification Office, 

1601 Lind Avenue, SW., Renton, Washington 

98057–3356; telephone (425) 917–6441; fax 

(425) 917–6590. Or, e-mail information to 9– 

ANM–Seattle-ACO–AMOC– 

Requests@faa.gov. 

(2) To request a different method of 

compliance or a different compliance time 

for this AD, follow the procedures in 14 CFR 

39.19. Before using any approved AMOC on 

any airplane to which the AMOC applies, 

notify your principal maintenance inspector 

(PMI) or principal avionics inspector (PAI), 

as appropriate, or lacking a principal 

inspector, your local Flight Standards District 

Office. The AMOC approval letter must 

specifically reference this AD. 

Material Incorporated by Reference 

(i) You must use Boeing Service Bulletin 

757–21–0109, Revision 1, dated October 30, 

2008, to do the actions required by this AD, 

unless the AD specifies otherwise. 

(1) The Director of the Federal Register 

approved the incorporation of this service 

information under 5 U.S.C. 552 (a) and 1 CFR 

part 51. 

(2) For service information identified in 

this AD, contact Boeing Commercial 

Airplanes, Attention: Data & Services 

Management, P. O. Box 3707, MC 2H–65, 

Seattle, Washington 98124–2207; telephone 

206–544–5000, extension 1; fax 206–766– 

5680; e-mail me.boecom@boeing.com; 

Internet https://www.myboeingfleet.com. 

(3) You may review copies of the service 

information at the FAA, Transport Airplane 

Directorate, 1601 Lind Avenue, SW., Renton, 

Washington. For information on the 

availability of this material at the FAA, call 

425–227–1221 or 425–227–1152. 

(4) You may also review copies of the 

service information that is incorporated by 

reference at the National Archives and 

Records Administration (NARA). For 

information on the availability of this 

material at NARA, call 202–741–6030, or go 

to: http://www.archives.gov/federal_register/ 

code_of_federal_regulations/

ibr_locations.html. 

Issued in Renton, Washington, on June 1, 

2009. 

Stephen P. Boyd, 

Acting Manager, Transport Airplane 

Directorate, Aircraft Certification Service. 

[FR Doc. E9–13137 Filed 6–10–09; 8:45 am] 

BILLING CODE 4910–13–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

21 CFR Part 520 

[Docket No. FDA–2009–N–0665] 

Oral Dosage Form New Animal Drugs; 

Methimazole 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Final rule. 

SUMMARY: The Food and Drug 

Administration (FDA) is amending the 

animal drug regulations to reflect the 

original approval of a new animal drug 

application (NADA) filed by Dechra, 

Ltd. The NADA provides for the 

veterinary prescription use of 

methimazole tablets in cats for 

treatment of hyperthyroidism. 

DATES: This rule is effective June 11, 

2009. 

FOR FURTHER INFORMATION CONTACT: 

Melanie R. Berson, Center for Veterinary 

Medicine (HFV–110), Food and Drug 

Administration, 7500 Standish Pl., 

Rockville, MD 20855, 240–276–8337, email: melanie.berson@fda.hhs.gov. 

SUPPLEMENTARY INFORMATION: Dechra, 

Ltd., Dechra House, Jamage Industrial 

Estate, Talke Pits, Stoke-on-Trent, 

Staffordshire, ST7 1XW, United 

Kingdom, filed NADA 141–292 that 

provides for veterinary prescription use 

of FELIMAZOLE (methimazole) Coated 

Tablets in cats for the treatment of 

hyperthyroidism. The NADA is 

approved as of May 27, 2009, and the 

regulations are amended in 21 CFR part 

520 to reflect the approval. 

In accordance with the freedom of 

information provisions of 21 CFR part 

20 and 21 CFR 514.11(e)(2)(ii), a 

summary of safety and effectiveness 

data and information submitted to 

support approval of this application 

may be seen in the Division of Dockets 

Management (HFA–305), Food and Drug 

Administration, 5630 Fishers Lane, rm. 

1061, Rockville, MD 20852, between 9 


cprice-sewell on PRODPC61 with RULES
Federal Register / Vol. 74, No. 111 / Thursday, June 11, 2009 / Rules and Regulations 27707 

a.m. and 4 p.m., Monday through 

Friday. 

Under section 512(c)(2)(F)(i) of the 

Federal Food, Drug, and Cosmetic Act 

(21 U.S.C. 360b(c)(2)(F)(i)), this 

approval qualifies for 5 years of 

marketing exclusivity beginning on the 

date of approval. 

FDA has determined under 21 CFR 

25.33 that this action is of a type that 

does not individually or cumulatively 

have a significant effect on the human 

environment. Therefore, neither an 

environmental assessment nor an 

environmental impact statement is 

required. 

This rule does not meet the definition 

of ‘‘rule’’ in 5 U.S.C. 804(3)(A) because 

it is a rule of ‘‘particular applicability.’’ 

Therefore, it is not subject to the 

congressional review requirements in 5 

U.S.C. 801–808. 

List of Subjects in 21 CFR Part 520 

Animal drugs. 

■ Therefore, under the Federal Food, 

Drug, and Cosmetic Act and under 

authority delegated to the Commissioner 

of Food and Drugs and redelegated to 

the Center for Veterinary Medicine, 21 

CFR part 520 is amended as follows: 

PART 520—ORAL DOSAGE FORM 

NEW ANIMAL DRUGS 

■ 1. The authority citation for 21 CFR 

part 520 continues to read as follows: 

Authority: 21 U.S.C. 360b. 

■ 2. Add § 520.1372 to read as follows: 

§ 520.1372 Methimazole. 

(a) Specifications. Each tablet 

contains 2.5 or 5 milligrams (mg) 

methimazole. 

(b) Sponsor. See No. 043264 in 

§ 510.600 of this chapter. 

(c) Conditions of use in cats—(1) 

Amount. The starting dose is 2.5 mg 

every 12 hours. Following 3 weeks of 

treatment, the dose should be titrated to 

effect based on individual serum total 

T4 levels and clinical response. 

(2) Indications for use. For the 

treatment of hyperthyroidism. 

(3) Limitations. Federal law restricts 

this drug to use by or on the order of 

a licensed veterinarian. 

Dated: June 5, 2009. 

Bernadette Dunham, 

Director, Center for Veterinary Medicine. 

[FR Doc. E9–13685 Filed 6–10–09; 8:45 am] 

BILLING CODE 4160–01–S 

DEPARTMENT OF THE TREASURY 

Fiscal Service 

31 CFR Part 285 

RIN 1510–AB19 

Debt Collection Authorities Under the 

Debt Collection Improvement Act of 

1996 

AGENCY: Financial Management Service, 

Fiscal Service, Treasury. 

ACTION: Interim final rule. 

SUMMARY: The Department of the 

Treasury, Financial Management 

Service, is amending its regulation 

governing the centralized offset of 

federal payments to collect nontax debts 

owed to the United States. The 

amendment removes the time limitation 

on the collection of nontax debts by 

centralized offset, consistent with a 

change in the statute on which it is 

based. The statutory change, enacted as 

part of the Food, Conservation and 

Energy Act of 2008, allows for the use 

of centralized offset of federal payments, 

including federal salary payments, to 

collect nontax debts owed to the United 

States irrespective of the amount of time 

the debt has been outstanding. 

DATES: This interim final rule is 

effective June 11, 2009. Comments must 

be received by August 10, 2009. 

ADDRESSES: The Financial Management 

Service (FMS) participates in the U.S. 

government’s eRulemaking Initiative by 

publishing rulemaking information on 

http://www.regulations.gov. 

Regulations.gov offers the public the 

ability to comment on, search, and view 

publicly available rulemaking materials, 

including comments received on rules. 

Comments on this rule, identified by 

docket FISCAL–FMS–2008–0002, 

should only be submitted using the 

following methods: 

Federal eRulemaking Portal: http:// 

www.regulations.gov. Follow the 

instructions on the Web site for 

submitting comments. 

Mail: Tom Dungan, Policy Analyst, 

Financial Management Service, 401 

14th Street, SW., Washington, DC 

20227. 

The fax and e-mail methods of 

submitting comments on rules to FMS 

have been retired. 

Instructions: All submissions received 

must include the agency name 

(‘‘Financial Management Service’’) and 

docket number FISCAL–FMS–2008– 

0002 for this rulemaking. In general, 

comments will be published on 

Regulations.gov without change, 

including any business or personal 

information provided. Comments 

received, including attachments and 

other supporting materials, are part of 

the public record and subject to public 

disclosure. Do not enclose any 

information in your comment or 

supporting materials that you consider 

confidential or inappropriate for public 

disclosure. 

You may also inspect and copy this 

proposed rule at: Treasury Department 

Library, Freedom of Information Act 

(FOIA) Collection, Room 1428, Main 

Treasury Building, 1500 Pennsylvania 

Avenue, NW., Washington, DC 20220. 

Before visiting, you must call (202) 622– 

0990 for an appointment. 

FOR FURTHER INFORMATION CONTACT: 

Thomas Dungan, Policy Analyst, at 

(202) 874–6660, or Tricia Long, Senior 

Attorney, at (202) 874–6680. 

SUPPLEMENTARY INFORMATION: 

I. Background 

The Food, Conservation and Energy 

Act of 2008, Public Law 110–334, 

Section 14219, 22 Stat. 923 (2008) (‘‘the 

Act’’) amended the Debt Collection Act 

of 1982 (as amended by the Debt 

Collection Improvement Act of 1996) to 

remove a restriction on the collection of 

debt by administrative offset, i.e., offset 

of payments pursuant to 31 U.S.C. 3716. 

Prior to this change, administrative 

offset to collect debt was only available 

if the debt was delinquent for a period 

of less than ten years. The amendment 

to the law allows for the collection of 

debt by administrative offset without 

any time limitation and applies to any 

debt outstanding on or after the date of 

the enactment of the Act. 

The changes to this rule conform to 

the statutory language by removing the 

ten-year time limitation on the 

collection of nontax debt by 

administrative offset, including 

centralized salary offset, by explicitly 

stating that no time limitation shall 

apply, and by explaining that by 

removing the time limitation, all debts, 

including debts that were ineligible for 

collection by offset prior to the removal 

of the time limitation, may now be 

collected by administrative offset and 

centralized salary offset. To avoid any 

undue hardship, we have added a 

requirement applicable to debts that 

were previously ineligible for collection 

by offset because they had been 

outstanding for more than ten years. For 

these debts, creditor agencies must 

certify to FMS that the notice of intent 

to offset was sent to the debtor after the 

debt became ten years delinquent. This 

is intended to alert the debtor that his 

debt may now be collected by offset and 

allows the debtor additional 


cprice-sewell on PRODPC61 with RULES